![](/img/cover-not-exists.png)
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
Rivkin, S E, Green, S, Metch, B, Glucksberg, H, Gad-el-Mawla, N, Constanzi, J J, Hoogstraten, B, Athens, J, Maloney, T, Osborne, C KVolume:
7
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.1989.7.9.1229
Date:
September, 1989
File:
PDF, 677 KB
english, 1989